JBIO Q2 2025 Earnings — Jade Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

JBIOJade Biosciences, Inc.

$491M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1,000

Operating Income

-$28M

Net Income

-$32M

EPS (Diluted)

$-1.13

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$37M

Free Cash Flow

-$37M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$224M

Total Liabilities

$22M

Stockholders' Equity

$202M

Cash & Equivalents

$221M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1,000	-$28,000	+96.4%
Operating Income	-$28M	-$26M	-6.2%
Net Income	-$32M	-$25M	-29.7%